https://www.marketscreener.com/quote/stock/ESPERION-THERAPEUTICS-INC-13479951/news/Esperion-U-S-FDA-Approves-Broad-New-Labels-for-NEXLETOL-and-NEXLIZET-to-Prevent-Heart-Attacks-and-46276813/?utm_source=telegram&utm_medium=social&utm_campaign=share